中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Pulmonary Codelivery of Doxorubicin and siRNA by pH-Sensitive Nanoparticles for Therapy of Metastatic Lung Cancer

文献类型:期刊论文

作者Xu,Caina; Wang,Ping; Zhang,Jingpeng; Tian,Huayu; Park,Kinam; Chen,Xuesi
刊名small
出版日期2015
卷号11期号:34页码:4321-4333
关键词CO-DELIVERY INHALATION TREATMENT INHALED DOXORUBICIN PLGA MICROPARTICLES NONVIRAL VECTORS ANTICANCER DRUG GENE DELIVERY SYSTEM OLIGONUCLEOTIDES NANOCARRIER
通讯作者tian,hy
英文摘要a pulmonary codelivery system that can simultaneously deliver doxorubicin (dox) and bcl2 sirna to the lungs provides a promising local treatment strategy for lung cancers. in this study, dox is conjugated onto polyethylenimine (pei) by using cis-aconitic anhydride (ca, a ph-sensitive linker) to obtain pei-ca-dox conjugates. the pei-ca-dox/sirna complex nanoparticles are formed spontaneously via electrostatic interaction between cationic pei-ca-dox and anionic sirna. the drug release experiment shows that dox releases faster at acidic ph than at ph 7.4. moreover, pei-ca-dox/bcl2 sirna complex nanoparticles show higher cytotoxicity and apoptosis induction in b16f10 cells than those treated with either dox or bcl2 sirna alone. when the codelivery systems are directly sprayed into the lungs of b16f10 melanoma-bearing mice, the pei-ca-dox/bcl2 sirna complex nanoparticles exhibit enhanced antitumor efficacy compared with the single delivery of dox or bcl2 sirna. compared with systemic delivery, most drug and sirna show a long-term retention in the lungs via pulmonary delivery, and a considerable number of the drug and sirna accumulate in tumor tissues of lungs, but rarely in normal lung tissues. the pei-ca-dox/bcl2 sirna complex nanoparticles are promising for the treatment of metastatic lung cancer by pulmonary delivery with low side effects on the normal tissues.
收录类别SCI
语种英语
WOS记录号WOS:000360852900010
源URL[http://ir.ciac.jl.cn/handle/322003/64598]  
专题长春应用化学研究所_长春应用化学研究所知识产出_期刊论文
推荐引用方式
GB/T 7714
Xu,Caina,Wang,Ping,Zhang,Jingpeng,et al. Pulmonary Codelivery of Doxorubicin and siRNA by pH-Sensitive Nanoparticles for Therapy of Metastatic Lung Cancer[J]. small,2015,11(34):4321-4333.
APA Xu,Caina,Wang,Ping,Zhang,Jingpeng,Tian,Huayu,Park,Kinam,&Chen,Xuesi.(2015).Pulmonary Codelivery of Doxorubicin and siRNA by pH-Sensitive Nanoparticles for Therapy of Metastatic Lung Cancer.small,11(34),4321-4333.
MLA Xu,Caina,et al."Pulmonary Codelivery of Doxorubicin and siRNA by pH-Sensitive Nanoparticles for Therapy of Metastatic Lung Cancer".small 11.34(2015):4321-4333.

入库方式: OAI收割

来源:长春应用化学研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。